Provided by Tiger Trade Technology Pte. Ltd.

DIAGENS-B

456.200
+6.2001.38%
Volume:73.50K
Turnover:33.48M
Market Cap:40.55B
PE:-543.73
High:470.000
Open:450.000
Low:421.000
Close:450.000
52wk High:765.500
52wk Low:178.000
Shares:88.88M
HK Float Shares:88.88M
Volume Ratio:0.69
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.839
ROE:-39.50%
ROA:-23.53%
PB:44.76
PE(LYR):-543.73
PS:189.25

Loading ...

DIAGENS-B Soars Over 110% in Pre-Market Trading, Signaling Strong Debut for Medical AI Giant

Stock News
·
Mar 27

Unlisted Trading Shows DIAGENS-B (02526) Surging Over 87% at Opening, Generating HK$4,310 Per Lot

Stock News
·
Mar 27

Diagens Soared 82% In Hong Kong’s Grey Market Trading

MT Newswires Live
·
Mar 27

Hangzhou Diagens Biotechnology Defines Comprehensive Mandate for Board Nomination Committee Ahead of HKEX Listing

Bulletin Express
·
Mar 27

Diagens Updates Articles of Association in Preparation for Hong Kong H-Share Listing

Bulletin Express
·
Mar 27

Diagens Establishes Comprehensive Audit Committee Framework to Strengthen Financial Oversight

Bulletin Express
·
Mar 27

IPO Margin Financing Statistics as of March 24

Stock News
·
Mar 24

DIAGENS-B Poised to Lead Hong Kong IPO Pipeline Amid "Dream Valuation" Frenzy

Stock News
·
Mar 24

Margin Financing Statistics for New Listings as of March 23

Stock News
·
Mar 23

Medical Imaging AI Pioneer Deshi's IPO Attracts Strong Long-Term Fund Interest

Deep News
·
Mar 23

Weekly IPO Review: Three New Listings Available for Subscription, Leading Mobile PCB Maker Enters Market

Deep News
·
Mar 23

DIAGENS-B: Medical Imaging AI Specialist with 8.4 Billion Float Shares - New Stock Analysis for March 2026 (02526.HK)

Deep News
·
Mar 22

IPO Margin Financing Statistics for March 20

Stock News
·
Mar 20

Landmark Listing: DIAGENS-B (02526) Debuts on HKEX as AI Healthcare's Pioneering Stock

Stock News
·
Mar 20

Hangzhou Diagens Biotechnology (02526) Launches Global Offering, Targeting Up to HK$112.50 per Share

Bulletin Express
·
Mar 20

BRIEF-Hangzhou Diagens Biotechnology Announces Global Offering

Reuters
·
Mar 20